Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2015-04-08

Clinical Trial Update: High-Resolution Microendoscopy to Guide Hysteroscopic Tumor Resection [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating high-resolution microendoscopy to guide hysteroscopic tumor resection in uterine cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Uterine Cancer | Phase 2 | Status: WITHDRAWN